Page 1 | Search Results | Blood | American Society of Hematology

1-20 of 155

Sort by

Sort Order Select

Journal Articles

CD47-blockade induces programmed necroptosis and complements the effects of BCL-2 inhibition in lymphoid malignancies

Blood (2025) 146 (Supplement 1): 1525.

https://doi.org/10.1182/blood-2025-1525

Published: 2025

Journal Articles

Pharmacokinetic failure of obinutuzumab due to massive third-space sequestration in a patient with high-burden follicular lymphoma: A rationale for therapeutic drug monitoring and dose intensification

Rong Xie, Qiang He, Hanheng Mai, Lili Feng, Yiwen Huang, Li Zhang, Ziqing Ma, Yuhong Ba, Kuntong Liu, Y. Lynn Wang, Ji Ma

Blood (2025) 146 (Supplement 1): 7131.

https://doi.org/10.1182/blood-2025-7131

Published: 2025

Journal Articles

Hetrombopag for the treatment of chemotherapy-induced thrombocytopenia in advanced solid tumors: A multicenter, randomized, double-blind, placebo-controlled phase III trial

Blood (2025) 146 (Supplement 1): 1256.

https://doi.org/10.1182/blood-2025-1256

Published: 2025

Journal Articles

First-line romiplostim combined with immunosuppressive therapy for severe aplastic anemia: A prospective, single-arm, Phase II study

Blood (2025) 146 (Supplement 1): 1426.

https://doi.org/10.1182/blood-2025-1426

Published: 2025

Journal Articles

Biomarkers for venous thromboembolism in children with central venous catheters

Neha Bhasin, Han Pham, Shravan Kannan, Christine Baird, Joshua Wischmeyer, Li Zhang, Marilyn Manco-Johnson, Steven Lentz

Blood (2025) 146 (Supplement 1): 3125.

https://doi.org/10.1182/blood-2025-3125

Published: 2025

Journal Articles

KP104, a bifunctional C5 mAb–Factor h fusion protein, demonstrates sustained long-term efficacy and safety in complement inhibitor–naïve PNH patients: 2-year results from A phase 2 study with 8-week post-treatment safety follow-up.

Li Zhang, Chen Yang, Changhe Yue, Jay Ma, Chaomei He, Ping Tsui, Helen Fu, Angela Yan, Wenru Song, Fengkui Zhang, Bing Han

Blood (2025) 146 (Supplement 1): 1118.

https://doi.org/10.1182/blood-2025-1118

Published: 2025

Journal Articles

Real-world poor prognostic impact of del(1p32) in newly diagnosed multiple myeloma among Asian populations

Ke Yuan, Yan Li, Wenjiao Tang, Hongyu Shen, Li Zhang, Ling Pan, Ting Niu

Blood (2025) 146 (Supplement 1): 7514.

https://doi.org/10.1182/blood-2025-7514

Published: 2025

Journal Articles

Therapeutic preclinical study on the synergy between CD73 inhibitors and selinexor for managing multiple myeloma

Chun-Li Zhang, Qiuxia Wei, Nigmat Rahim, Gang Bian, Chaoling Wu, Jing Wang, Ping Yang, Jiahui Hua, Mingxia Zhu, Yingtong Chen, Yan Liu, Shuang Gao, Bing Hou, Weilong Zhang, Hongmei Jing

Blood (2025) 146 (Supplement 1): 7455.

https://doi.org/10.1182/blood-2025-7455

Published: 2025

Journal Articles

Vitamin K3 metabolic fate determines pro-survival or ferroptotic outcomes in multiple myeloma via UBIAD1 and reductase axis

Yonggang Zhang, Linxiu Mao, Xiaoyu Ran, Li Zhang, Jing Tan

Blood (2025) 146 (Supplement 1): 1534.

https://doi.org/10.1182/blood-2025-1534

Published: 2025

Journal Articles

The role of red blood cell lifespan in evaluating the condition of patients with paroxysmal nocturnal hemoglobinuria treated with complement inhibitors

Lei Ye, Xin Zhao, fengkui zhang, Li Zhang

Blood (2025) 146 (Supplement 1): 4971.

https://doi.org/10.1182/blood-2025-4971

Published: 2025

Journal Articles

Effect and mechanism of allopurinol in ALL maintenance therapy: Reducing hepatotoxicity and improving myelosuppression effect via TPMT inhibition and increased DNA-thioguanine levels

Yanping Guan, Xiao-Li Zhang, Jian Wang, Min Huang, Libin Huang, Xueding Wang, Dun-Hua Zhou

Blood (2025) 146 (Supplement 1): 6852.

https://doi.org/10.1182/blood-2025-6852

Published: 2025

Journal Articles

Efficacy and safety of NTQ5082 monotherapy in complement-inhibitor-Naïve patients with paroxysmal nocturnal hemoglobinuria: A proof-of-concept, multicenter, randomized, open-label phase 2 study

Fengkui Zhang, Hongyan Tong, Linghui Xia, Li Zhang, Gaixiang Xu, Lin Liu, Yumeng Zhou, Rongfeng Zhou

Blood (2025) 146 (Supplement 1): 982.

https://doi.org/10.1182/blood-2025-982

Published: 2025

Journal Articles

Clinical characteristics and treatment patterns of elderly patients living with Mantle Cell Lymphoma

Sachi Singhal, Li Zhang, Luke Helstrom, Marcus Messmer

Blood (2025) 146 (Supplement 1): 2711.

https://doi.org/10.1182/blood-2025-2711

Published: 2025

Journal Articles

S100A12-Orchestrated Macrophage-ER stress crosstalk in MDS: Mechanisms and precision therapeutic targeting

Li Zhang, Liansheng Zhang, Ting Niu, Lijuan li

Blood (2025) 146 (Supplement 1): 6769.

https://doi.org/10.1182/blood-2025-6769

Published: 2025

Journal Articles

Decitabine enhances tumor immunogenicity via transposable element reactivation but concurrently induces oncogene expression in Acute Myeloid Leukemia

Dharambir Kashyap, Riya Sharma, Malak Khalife, LI Zhang, Huda Salman

Blood (2025) 146 (Supplement 1): 6766.

https://doi.org/10.1182/blood-2025-6766

Published: 2025

Journal Articles

Early reduction of BCR-ABL at 3 months predicts deeper molecular remission in pediatric CML

Xingchen Wang, Wenbin An, Bang Zhang, Yunlong Chen, yang wan, Xiaolan Li, Lipeng Liu, Fang Liu, Li Zhang, Yao Zou, Xiaojuan Chen, Yumei Chen, Ye Guo, Tianyuan Hu, Yingchi Zhang, Xiaofan Zhu, Wenyu Yang

Blood (2025) 146 (Supplement 1): 3783.

https://doi.org/10.1182/blood-2025-3783

Published: 2025

Journal Articles

Clinical Characteristics and Outcomes of Infant Acute Lymphoblastic Leukemia from a Single Institute in China

Xiaolan Li, Fang Liu, Yang Wan, Ye Guo, Xiaojuan Chen, Yumei Chen, Yao Zou, Li Zhang, Xiaofan Zhu, Wenyu Yang

Blood (2024) 144 (Supplement 1): 5862.

https://doi.org/10.1182/blood-2024-201999

Published: 2024

Journal Articles

AML Cells Have Increased Mitochondrial RNA Degradation and Inhibiting This Degradation Promotes Cell Differentiation, Decreases Viability, and Increases Sensitivity to Immune-Mediated Killing

Geethu Emily Thomas, Kazem Nouri, Rose Hurren, JongBok Lee, Veronique Voisin, Yongran Yan, Neil Maclean, Marcela Gronda, Yulia Jitkova, Taylor Barbieri, Li Ma, Xiaoming Wang, Andrea Arruda, Mark D. Minden, Li Zhang, Aaron D Schimmer

Blood (2024) 144 (Supplement 1): 2723.

https://doi.org/10.1182/blood-2024-194861

Published: 2024

Journal Articles

A Multicenter Clinical Study of Cccg - APL-2017 in the Treatment of Children with Acute Promyelocytic Leukemia

Blood (2024) 144 (Supplement 1): 2899.

https://doi.org/10.1182/blood-2024-203264

Published: 2024

Journal Articles

Efficacy and Prognostic Assessment of Chemotherapy-Bridged Transplantation in Pediatric Patients with Advanced Myelodysplastic Syndromes

Xingchen Wang, Yunlong Chen, Chenmeng Liu, Yang Wan, Wenbin An, Xiaolan Li, Lipeng Liu, Fang Liu, Li Zhang, Yao Zou, Xiaojuan Chen, Yumei Chen, Ye Guo, Xiaofan Zhu, Wenyu Yang

Blood (2024) 144 (Supplement 1): 6740.

https://doi.org/10.1182/blood-2024-204699

Published: 2024

Update search

NARROW

Publications

Format

Subjects

Article Type

Topics

Date

Availability

CD47-blockade induces programmed necroptosis and complements the effects of BCL-2 inhibition in lymphoid malignancies

Pharmacokinetic failure of obinutuzumab due to massive third-space sequestration in a patient with high-burden follicular lymphoma: A rationale for therapeutic drug monitoring and dose intensification

Hetrombopag for the treatment of chemotherapy-induced thrombocytopenia in advanced solid tumors: A multicenter, randomized, double-blind, placebo-controlled phase III trial

First-line romiplostim combined with immunosuppressive therapy for severe aplastic anemia: A prospective, single-arm, Phase II study

Biomarkers for venous thromboembolism in children with central venous catheters

KP104, a bifunctional C5 mAb–Factor h fusion protein, demonstrates sustained long-term efficacy and safety in complement inhibitor–naïve PNH patients: 2-year results from A phase 2 study with 8-week post-treatment safety follow-up.

Real-world poor prognostic impact of del(1p32) in newly diagnosed multiple myeloma among Asian populations

Therapeutic preclinical study on the synergy between CD73 inhibitors and selinexor for managing multiple myeloma

Vitamin K3 metabolic fate determines pro-survival or ferroptotic outcomes in multiple myeloma via UBIAD1 and reductase axis

The role of red blood cell lifespan in evaluating the condition of patients with paroxysmal nocturnal hemoglobinuria treated with complement inhibitors

Effect and mechanism of allopurinol in ALL maintenance therapy: Reducing hepatotoxicity and improving myelosuppression effect via TPMT inhibition and increased DNA-thioguanine levels

Efficacy and safety of NTQ5082 monotherapy in complement-inhibitor-Naïve patients with paroxysmal nocturnal hemoglobinuria: A proof-of-concept, multicenter, randomized, open-label phase 2 study

Clinical characteristics and treatment patterns of elderly patients living with Mantle Cell Lymphoma

S100A12-Orchestrated Macrophage-ER stress crosstalk in MDS: Mechanisms and precision therapeutic targeting

Decitabine enhances tumor immunogenicity via transposable element reactivation but concurrently induces oncogene expression in Acute Myeloid Leukemia

Early reduction of BCR-ABL at 3 months predicts deeper molecular remission in pediatric CML

Clinical Characteristics and Outcomes of Infant Acute Lymphoblastic Leukemia from a Single Institute in China

AML Cells Have Increased Mitochondrial RNA Degradation and Inhibiting This Degradation Promotes Cell Differentiation, Decreases Viability, and Increases Sensitivity to Immune-Mediated Killing

A Multicenter Clinical Study of Cccg - APL-2017 in the Treatment of Children with Acute Promyelocytic Leukemia

Efficacy and Prognostic Assessment of Chemotherapy-Bridged Transplantation in Pediatric Patients with Advanced Myelodysplastic Syndromes

Email alerts

ASH Publications

American Society of Hematology

Update search

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only